Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values CYR61 3491 broad.mit.edu 37 1 86047880 86047881 + In_Frame_Ins INS - - TGG TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr1:86047880_86047881insTGG uc001dle.3 + 2 771_772 c.547_548insTGG c.(547-549)ctg>cTGGtg p.183_184insV CYR61_uc021opf.1_In_Frame_Ins_p.116_117insV NM_001554 NP_001545 O00622 CYR61_HUMAN Homo sapiens cysteine-rich, angiogenic inducer, 61 (CYR61), mRNA. 183 cell proliferation|chemotaxis|positive regulation of BMP signaling pathway|positive regulation of cell migration|positive regulation of osteoblast differentiation|positive regulation of osteoblast proliferation|positive regulation of protein kinase activity|positive regulation of protein phosphorylation|positive regulation of transcription from RNA polymerase II promoter|regulation of cell growth|regulation of ERK1 and ERK2 cascade|wound healing, spreading of cells extracellular region heparin binding|insulin-like growth factor binding central_nervous_system(1)|endometrium(1)|large_intestine(2)|prostate(1) 5 all cancers(265;0.0216)|Epithelial(280;0.0441) TGGCAAGGAGCTGGGATTCGAT 0.559 OREG0013583 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) NBPF10 400818 broad.mit.edu 37 1 144825409 144825409 + Missense_Mutation SNP G G A rs558823 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr1:144825409G>A uc009wig.1 + 17 2323 c.2129G>A c.(2128-2130)gGt>gAt p.G710D NBPF10_uc010oxo.1_Missense_Mutation_p.G637D|NBPF10_uc010oxn.1_Intron|NBPF10_uc021oth.1_Intron|NBPF10_uc021otj.1_Intron|NBPF10_uc021oto.1_Intron|NBPF10_uc021otr.1_Intron|NBPF10_uc021ots.1_Intron|NBPF10_uc021otv.1_Missense_Mutation_p.G527D|NBPF10_uc001ekk.1_Intron|NBPF10_uc010oyd.1_Intron|NBPF10_uc010oye.2_Missense_Mutation_p.G513D|NBPF10_uc001eli.3_Non-coding_Transcript|PDE4DIP_uc001elk.2_Intron|PDE4DIP_uc001ell.2_Intron|PDE4DIP_uc001elm.4_Intron|PDE4DIP_uc001eln.4_Intron|PDE4DIP_uc001elo.3_Intron|NBPF10_uc021ouf.1_Missense_Mutation_p.G372D NM_001037675 NP_001032764 A6NDV3 A6NDV3_HUMAN Homo sapiens neuroblastoma breakpoint family, member 9 (NBPF9), mRNA. 712 NS(3)|breast(1)|central_nervous_system(3)|endometrium(12)|kidney(23)|lung(15)|ovary(1)|prostate(7)|skin(6)|urinary_tract(2) 73 all_hematologic(923;0.032) Colorectal(1306;1.36e-07)|KIRC - Kidney renal clear cell carcinoma(1967;0.00258) GACTCACTGGGTAGATGGTAT 0.493 PIGR 5284 broad.mit.edu 37 1 207110686 207110686 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr1:207110686C>T uc001hez.3 - 3 983 c.799G>A c.(799-801)Gcc>Acc p.A267T PIGR_uc009xbz.3_Missense_Mutation_p.A267T NM_002644 NP_002635 P01833 PIGR_HUMAN Homo sapiens polymeric immunoglobulin receptor (PIGR), mRNA. 267 Ig-like V-type 3. extracellular region|integral to plasma membrane protein binding central_nervous_system(2)|endometrium(5)|kidney(3)|large_intestine(7)|lung(15)|ovary(1)|pancreas(1)|prostate(1)|skin(4)|stomach(3)|upper_aerodigestive_tract(2)|urinary_tract(1) 45 AGAAATTTGGCCACGTTTGCC 0.592 LIN9 286826 broad.mit.edu 37 1 226426780 226426780 + Silent SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr1:226426780G>A uc001hqa.2 - 11 1495 c.1185C>T c.(1183-1185)ccC>ccT p.P395P LIN9_uc001hqb.2_Silent_p.P360P|LIN9_uc001hqc.3_Silent_p.P327P|LIN9_uc009xel.1_Silent_p.P360P NM_173083 NP_775106 Q5TKA1 LIN9_HUMAN Homo sapiens lin-9 homolog (C. elegans) (LIN9), mRNA. 379 cell cycle|DNA replication nucleoplasm p.P395S(2) breast(3)|endometrium(4)|kidney(2)|large_intestine(6)|lung(9)|ovary(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(1) 28 Breast(184;0.158) GBM - Glioblastoma multiforme(131;0.131) CAATGCTGATGGGCATGGAAT 0.343 ADARB2 105 broad.mit.edu 37 10 1405297 1405297 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr10:1405297C>T uc009xhq.3 - 2 1329 c.1003G>A c.(1003-1005)Gca>Aca p.A335T NM_018702 NP_061172 Q9NS39 RED2_HUMAN Homo sapiens adenosine deaminase, RNA-specific, B2 (ADARB2), mRNA. 335 DRBM 2. mRNA processing mitochondrion|nucleus adenosine deaminase activity|double-stranded RNA binding|metal ion binding|single-stranded RNA binding breast(2)|central_nervous_system(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(7)|lung(17)|prostate(2)|skin(1)|urinary_tract(1) 41 all_epithelial(10;0.059)|Colorectal(49;0.0815) all cancers(11;0.0224)|GBM - Glioblastoma multiforme(2;0.0414)|Epithelial(11;0.165) TCCTGCAGTGCGGCCTGCGCG 0.746 FGFR2 2263 broad.mit.edu 37 10 123298220 123298220 + Missense_Mutation SNP G G T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr10:123298220G>T uc021pzz.1 - 5 1281 c.634C>A c.(634-636)Cag>Aag p.Q212K FGFR2_uc021pzv.1_Missense_Mutation_p.Q212K|FGFR2_uc021pzw.1_Missense_Mutation_p.Q97K|FGFR2_uc021pzx.1_Missense_Mutation_p.Q123K|FGFR2_uc021pzy.1_Missense_Mutation_p.Q212K|FGFR2_uc010qtl.2_Missense_Mutation_p.Q212K|FGFR2_uc010qtm.2_Missense_Mutation_p.Q97K|FGFR2_uc021qaa.1_Missense_Mutation_p.Q212K|FGFR2_uc021qab.1_Missense_Mutation_p.Q123K|FGFR2_uc021qac.1_Missense_Mutation_p.Q142K|FGFR2_uc001lfn.4_Non-coding_Transcript|FGFR2_uc010qtn.2_Missense_Mutation_p.Q231K|FGFR2_uc010qto.2_Missense_Mutation_p.Q116K|FGFR2_uc001lfo.1_Missense_Mutation_p.Q231K|FGFR2_uc010qtp.2_Missense_Mutation_p.Q231K|FGFR2_uc010qtq.2_Missense_Mutation_p.Q231K NM_000141 NP_000132 P21802 FGFR2_HUMAN Homo sapiens fibroblast growth factor receptor 2 (FGFR2), transcript variant 1, mRNA. 212 Ig-like C2-type 2. angiogenesis|axonogenesis|bone mineralization|bone morphogenesis|branch elongation involved in salivary gland morphogenesis|branching involved in embryonic placenta morphogenesis|branching morphogenesis of a nerve|bud elongation involved in lung branching|cell fate commitment|cell growth|cell-cell signaling|cellular response to protein stimulus|embryonic digestive tract morphogenesis|embryonic pattern specification|epithelial cell proliferation involved in salivary gland morphogenesis|fibroblast growth factor receptor signaling pathway involved in hemopoiesis|fibroblast growth factor receptor signaling pathway involved in mammary gland specification|fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptosis in bone marrow|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development|fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow|hair follicle morphogenesis|insulin receptor signaling pathway|lacrimal gland development|lateral sprouting from an epithelium|limb bud formation|lung alveolus development|lung lobe morphogenesis|lung-associated mesenchyme development|mammary gland bud formation|membranous septum morphogenesis|mesenchymal cell differentiation involved in lung development|mesenchymal cell proliferation involved in lung development|midbrain development|multicellular organism growth|negative regulation of transcription from RNA polymerase II promoter|odontogenesis|organ growth|otic vesicle formation|outflow tract septum morphogenesis|positive regulation of canonical Wnt receptor signaling pathway|positive regulation of cardiac muscle cell proliferation|positive regulation of cell cycle|positive regulation of cell division|positive regulation of epithelial cell proliferation involved in lung morphogenesis|positive regulation of ERK1 and ERK2 cascade|positive regulation of mesenchymal cell proliferation|positive regulation of transcription from RNA polymerase II promoter|post-embryonic development|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate epithelial cord elongation|pyramidal neuron development|regulation of branching involved in prostate gland morphogenesis|regulation of cell fate commitment|regulation of fibroblast growth factor receptor signaling pathway|regulation of multicellular organism growth|regulation of smooth muscle cell differentiation|regulation of smoothened signaling pathway|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development|ureteric bud development|ventricular cardiac muscle tissue morphogenesis|ventricular zone neuroblast division cell cortex|cell surface|excitatory synapse|extracellular region|integral to membrane|nucleus|plasma membrane ATP binding|fibroblast growth factor binding|fibroblast growth factor receptor activity|heparin binding|protein binding p.Q212K(2)|p.N211I(1) breast(3)|central_nervous_system(3)|cervix(2)|endometrium(98)|haematopoietic_and_lymphoid_tissue(4)|kidney(4)|large_intestine(7)|lung(21)|ovary(4)|skin(30)|soft_tissue(1)|stomach(2)|upper_aerodigestive_tract(2) 181 Lung NSC(174;0.0841)|all_lung(145;0.106)|all_neural(114;0.107) STAD - Stomach adenocarcinoma(1;7.52e-05)|all cancers(1;0.0722) all cancers(201;9.73e-05)|GBM - Glioblastoma multiforme(135;0.0845) Palifermin(DB00039) CTCCAGTGCTGGTTTCGTACC 0.418 5 Mis """gastric. NSCLC, endometrial""" """Crouzon, Pfeiffer, and Apert syndromes""" Saethre-Chotzen syndrome;Apert syndrome SLC22A9 114571 broad.mit.edu 37 11 63141216 63141216 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr11:63141216C>T uc001nww.3 + 2 875 c.607C>T c.(607-609)Cgc>Tgc p.R203C SLC22A9_uc001nwx.3_Intron NM_080866 NP_543142 Q8IVM8 S22A9_HUMAN Homo sapiens solute carrier family 22 (organic anion transporter), member 9 (SLC22A9), mRNA. 203 transmembrane transport integral to membrane breast(2)|cervix(1)|endometrium(2)|kidney(2)|large_intestine(3)|lung(7)|upper_aerodigestive_tract(1) 18 CTGCTCACTACGCTTCTTGTC 0.458 TSKU 25987 broad.mit.edu 37 11 76506917 76506917 + Missense_Mutation SNP T T G TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr11:76506917T>G uc021qno.1 + 0 257 c.257T>G c.(256-258)tTg>tGg p.L86W TSKU_uc001oxt.3_Missense_Mutation_p.L86W NM_015516 NP_056331 Q8WUA8 TSK_HUMAN Homo sapiens tsukushi small leucine rich proteoglycan homolog (Xenopus laevis) (TSKU), mRNA. 86 extracellular region NS(1)|large_intestine(4)|lung(6)|urinary_tract(1) 12 Ovarian(111;0.112) TACACGACGTTGGCTGGCCTG 0.632 GPR19 2842 broad.mit.edu 37 12 12814147 12814155 + In_Frame_Del DEL ATTTGGTGG ATTTGGTGG - rs61733942 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr12:12814147_12814155delATTTGGTGG uc001rar.3 - 1 1421_1429 c.1228_1236delCCACCAAAT c.(1228-1236)ccaccaaatdel p.PPN410del GPR19_uc001raq.2_In_Frame_Del_p.PPN410del|GPR19_uc021qvj.1_In_Frame_Del_p.PPN410del NM_006143 NP_006134 Q15760 GPR19_HUMAN Homo sapiens G protein-coupled receptor 19 (GPR19), mRNA. 410 integral to plasma membrane G-protein coupled receptor activity breast(1)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(4)|lung(5)|ovary(1)|skin(1)|upper_aerodigestive_tract(1) 17 Prostate(47;0.0802) BRCA - Breast invasive adenocarcinoma(232;0.048) AGACAAAAGTATTTGGTGGATTTGAGTTA 0.340 CDKN1B 1027 broad.mit.edu 37 12 12871093 12871093 + Missense_Mutation SNP A A G TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr12:12871093A>G uc001rat.2 + 0 792 c.320A>G c.(319-321)cAg>cGg p.Q107R NM_004064 NP_004055 P46527 CDN1B_HUMAN Homo sapiens cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B), mRNA. 107 autophagic cell death|cell cycle arrest|cellular response to lithium ion|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|G1 phase of mitotic cell cycle|G1/S transition of mitotic cell cycle|induction of apoptosis|negative regulation of cell growth|negative regulation of transcription, DNA-dependent|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of protein catabolic process|S phase of mitotic cell cycle cytosol|endosome|nucleoplasm cyclin-dependent protein kinase inhibitor activity|protein phosphatase binding|transforming growth factor beta receptor, cytoplasmic mediator activity breast(1)|large_intestine(3)|lung(3)|ovary(1)|prostate(5) 13 Prostate(47;0.0322)|all_epithelial(100;0.159) BRCA - Breast invasive adenocarcinoma(232;0.0336) CAGGAGAGCCAGGATGTCAGC 0.642 ITGA7 3679 broad.mit.edu 37 12 56078847 56078847 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr12:56078847C>T uc001shh.3 - 24 3641 c.3421G>A c.(3421-3423)Gcc>Acc p.A1141T ITGA7_uc001shg.3_Missense_Mutation_p.A1137T|ITGA7_uc010sps.2_Missense_Mutation_p.A1044T|ITGA7_uc001shf.3_3'UTR|ITGA7_uc009znw.3_Missense_Mutation_p.A384T|ITGA7_uc009znx.3_Missense_Mutation_p.A1018T NM_001144996 NP_001138468 Q13683 ITA7_HUMAN Homo sapiens integrin, alpha 7 (ITGA7), transcript variant 1, mRNA. 1181 cell-matrix adhesion|integrin-mediated signaling pathway|muscle organ development|regulation of cell shape integrin complex receptor activity p.A1141T(1)|p.A1137T(1) breast(2)|central_nervous_system(1)|cervix(1)|endometrium(6)|kidney(1)|large_intestine(10)|lung(16)|ovary(2)|prostate(2)|skin(5)|soft_tissue(1)|upper_aerodigestive_tract(2)|urinary_tract(1) 50 GGAACCTAGGCGGTGCCTGGC 0.697 ANKRD52 283373 broad.mit.edu 37 12 56639298 56639298 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr12:56639298G>A uc001skm.4 - 20 2357 c.2267C>T c.(2266-2268)aCg>aTg p.T756M NM_173595 NP_775866 Q8NB46 ANR52_HUMAN Homo sapiens ankyrin repeat domain 52 (ANKRD52), mRNA. 756 protein binding p.T756M(2) endometrium(9)|kidney(2)|large_intestine(8)|lung(6)|ovary(2)|prostate(1)|skin(1) 29 GTGAATGGGCGTGCGGCCCTT 0.627 ACADS 35 broad.mit.edu 37 12 121176680 121176680 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr12:121176680G>A uc001tza.4 + 7 1109 c.991G>A c.(991-993)Gct>Act p.A331T ACADS_uc010szl.1_Missense_Mutation_p.A327T NM_000017 NP_000008 P16219 ACADS_HUMAN Homo sapiens acyl-CoA dehydrogenase, C-2 to C-3 short chain (ACADS), nuclear gene encoding mitochondrial protein, mRNA. 331 mitochondrial matrix butyryl-CoA dehydrogenase activity p.R330H(2)|p.R330C(1) central_nervous_system(3)|endometrium(1)|kidney(1)|large_intestine(1)|lung(5)|prostate(3) 14 all_neural(191;0.0684)|Medulloblastoma(191;0.0922) Lung NSC(355;0.163) NADH(DB00157) GACCTGGCGCGCTGCCATGCT 0.637 WDR66 144406 broad.mit.edu 37 12 122437781 122437781 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr12:122437781G>A uc009zxk.3 + 19 3325 c.3166G>A c.(3166-3168)Ggt>Agt p.G1056S NM_144668 NP_653269 Q8TBY9 WDR66_HUMAN Homo sapiens WD repeat domain 66 (WDR66), transcript variant 1, mRNA. 1056 calcium ion binding breast(1)|central_nervous_system(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(11)|liver(2)|lung(13)|ovary(2)|prostate(2)|skin(2)|soft_tissue(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 43 all_neural(191;0.0496)|Medulloblastoma(191;0.0922) OV - Ovarian serous cystadenocarcinoma(86;0.000155)|Epithelial(86;0.000634)|BRCA - Breast invasive adenocarcinoma(302;0.248) TGAGGTGCTCGGTTATACCAA 0.448 TNFSF11 8600 broad.mit.edu 37 13 43180986 43180986 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr13:43180986C>T uc001uyu.2 + 4 1035 c.886C>T c.(886-888)Ccc>Tcc p.P296S TNFSF11_uc001uyt.2_Missense_Mutation_p.P223S NM_003701 NP_143026 O14788 TNF11_HUMAN Homo sapiens tumor necrosis factor (ligand) superfamily, member 11 (TNFSF11), transcript variant 1, mRNA. 296 immune response|monocyte chemotaxis|osteoclast differentiation|positive regulation of bone resorption|positive regulation of corticotropin-releasing hormone secretion|positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|positive regulation of homotypic cell-cell adhesion|positive regulation of NF-kappaB transcription factor activity|positive regulation of osteoclast differentiation|positive regulation of T cell activation cytoplasm|extracellular space|integral to plasma membrane cytokine activity|receptor activity|tumor necrosis factor receptor binding kidney(1)|large_intestine(4)|lung(3)|prostate(1)|urinary_tract(1) 10 Lung NSC(96;1.11e-05)|Breast(139;0.00868)|Prostate(109;0.0181)|Lung SC(185;0.0262)|Hepatocellular(98;0.114) OV - Ovarian serous cystadenocarcinoma(117;0.000249)|GBM - Glioblastoma multiforme(144;0.00119)|BRCA - Breast invasive adenocarcinoma(63;0.073) GGTCTCCAACCCCTCCTTACT 0.418 RB1 5925 broad.mit.edu 37 13 49033967 49033967 + Nonsense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr13:49033967C>T uc001vcb.3 + 19 2270 c.2104C>T c.(2104-2106)Caa>Taa p.Q702* NM_000321 NP_000312 P06400 RB_HUMAN Homo sapiens retinoblastoma 1 (RB1), mRNA. 702 Domain B.|Pocket; binds T and E1A. androgen receptor signaling pathway|cell cycle arrest|chromatin remodeling|G1 phase of mitotic cell cycle|interspecies interaction between organisms|maintenance of mitotic sister chromatid cohesion|mitotic cell cycle G1/S transition checkpoint|myoblast differentiation|negative regulation of cell growth|negative regulation of protein kinase activity|negative regulation of S phase of mitotic cell cycle|negative regulation of sequence-specific DNA binding transcription factor activity|positive regulation of mitotic metaphase/anaphase transition|protein localization to chromosome, centromeric region|Ras protein signal transduction|regulation of centromere complex assembly|regulation of cohesin localization to chromatin|regulation of lipid kinase activity|regulation of transcription involved in G1/S phase of mitotic cell cycle|S phase of mitotic cell cycle|sister chromatid biorientation chromatin|PML body|Rb-E2F complex|SWI/SNF complex androgen receptor binding|DNA binding|kinase binding|phosphoprotein binding|sequence-specific DNA binding transcription factor activity|transcription coactivator activity|transcription factor binding|ubiquitin protein ligase binding p.0?(15)|p.?(12)|p.Q702*(4)|p.Q702K(2) NS(3)|adrenal_gland(1)|bone(22)|breast(30)|central_nervous_system(48)|cervix(3)|endometrium(14)|eye(95)|gastrointestinal_tract_(site_indeterminate)(1)|haematopoietic_and_lymphoid_tissue(20)|kidney(3)|large_intestine(10)|liver(3)|lung(153)|oesophagus(1)|ovary(13)|pancreas(5)|pituitary(1)|prostate(14)|salivary_gland(2)|skin(9)|soft_tissue(9)|stomach(4)|upper_aerodigestive_tract(1)|urinary_tract(31) 496 all_cancers(8;6.9e-71)|all_epithelial(8;4.61e-22)|Acute lymphoblastic leukemia(8;1.1e-21)|all_hematologic(8;2.3e-21)|all_lung(13;1.51e-09)|Lung NSC(96;7.03e-07)|Breast(56;1.53e-05)|Prostate(109;0.000493)|Myeloproliferative disorder(33;0.0179)|Hepatocellular(98;0.0207)|all_neural(104;0.0227)|Glioma(44;0.0286)|Lung SC(185;0.0301) GBM - Glioblastoma multiforme(2;9.98e-18)|LUSC - Lung squamous cell carcinoma(3;0.013) Insulin Glargine recombinant(DB00047)|Insulin Lyspro recombinant(DB00046)|Insulin recombinant(DB00030)|Insulin, porcine(DB00071) GCATTTGGACCAAGTAAGAAA 0.398 6 """D, Mis, N, F, S""" """retinoblastoma, sarcoma, breast, small cell lung""" """retinoblastoma, sarcoma, breast, small cell lung""" Hereditary Retinoblastoma TCGA GBM(7;6.82e-08)|TSP Lung(12;0.097)|TCGA Ovarian(6;0.080) POTEM 641455 broad.mit.edu 37 14 20010235 20010235 + Missense_Mutation SNP A A G TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr14:20010235A>G uc001vwc.3 - 4 975 c.923T>C c.(922-924)gTt>gCt p.V308A POTEM_uc001vwb.3_Non-coding_Transcript|P712P_uc001vwd.3_Non-coding_Transcript NM_001145442 NP_001138914 A6NI47 POTEM_HUMAN Homo sapiens POTE ankyrin domain family, member M (POTEM), mRNA. 308 endometrium(4)|kidney(1)|lung(4) 9 AAGTATGAGAACAGTTCTAAA 0.368 HCN4 10021 broad.mit.edu 37 15 73614906 73614906 + Silent SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr15:73614906C>T uc002avp.3 - 7 4522 c.3528G>A c.(3526-3528)ggG>ggA p.G1176G NM_005477 NP_005468 Q9Y3Q4 HCN4_HUMAN Homo sapiens hyperpolarization activated cyclic nucleotide-gated potassium channel 4 (HCN4), mRNA. 1176 blood circulation|muscle contraction integral to membrane cAMP binding|protein binding|sodium channel activity|voltage-gated potassium channel activity NS(2)|biliary_tract(1)|breast(1)|endometrium(4)|kidney(1)|large_intestine(13)|liver(1)|lung(18)|ovary(6)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(1) 55 COAD - Colon adenocarcinoma(1;0.142) GAGGGGGCCCCCCAGAAGAGG 0.627 ACSM5 54988 broad.mit.edu 37 16 20439127 20439127 + Silent SNP G G A rs12922063 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr16:20439127G>A uc002dhe.3 + 6 1086 c.939G>A c.(937-939)ccG>ccA p.P313P NM_017888 NP_060358 Q6NUN0 ACSM5_HUMAN Homo sapiens acyl-CoA synthetase medium-chain family member 5 (ACSM5), mRNA. 313 fatty acid metabolic process mitochondrial matrix ATP binding|butyrate-CoA ligase activity|GTP binding|metal ion binding breast(1)|endometrium(6)|kidney(2)|large_intestine(6)|lung(28)|ovary(3)|prostate(1)|skin(3)|urinary_tract(1) 51 CCAAATTCCCGATAACCACCC 0.473 ITGAD 3681 broad.mit.edu 37 16 31409190 31409190 + Silent SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr16:31409190G>A uc010cap.1 + 4 436 c.387G>A c.(385-387)tcG>tcA p.S129S ITGAD_uc010vfl.1_Silent_p.S129S|ITGAD_uc002ebv.1_Silent_p.S129S|ITGAD_uc002ebw.1_5'UTR NM_005353 NP_005344 Q13349 ITAD_HUMAN Homo sapiens integrin, alpha D (ITGAD), mRNA. 129 cell-cell adhesion|cell-matrix adhesion|immune response|integrin-mediated signaling pathway integrin complex receptor activity p.G128C(1) breast(1)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(10)|liver(2)|lung(43)|ovary(1)|prostate(2)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1) 71 TGCTGGGCTCGCGCTGGGAGA 0.642 CES1P1 51716 broad.mit.edu 37 16 55803916 55803916 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr16:55803916G>A uc002eik.3 + 3 491 c.40G>A c.(40-42)Gca>Aca p.A14T CES1P1_uc010cce.3_Missense_Mutation_p.A14T Homo sapiens carboxylesterase 1 pseudogene 1 (CES1P1), non-coding RNA. GGTGGGTGCGGCATCAACCTA 0.562 CETP 1071 broad.mit.edu 37 16 57007243 57007243 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr16:57007243G>A uc002eki.2 + 9 808 c.751_splice c.e9-1 p.G251_splice CETP_uc002ekj.2_Intron NM_000078 NP_000069 P11597 CETP_HUMAN Homo sapiens cholesteryl ester transfer protein, plasma (CETP), mRNA. 251 cholesterol homeostasis|cholesterol metabolic process|high-density lipoprotein particle remodeling|lipoprotein metabolic process|low-density lipoprotein particle remodeling|phosphatidylcholine metabolic process|phospholipid homeostasis|receptor-mediated endocytosis|regulation of cholesterol efflux|triglyceride homeostasis|triglyceride metabolic process|very-low-density lipoprotein particle remodeling high-density lipoprotein particle|vesicle cholesterol binding|cholesterol transporter activity|phosphatidylcholine binding|phospholipid transporter activity|triglyceride binding NS(1)|breast(3)|central_nervous_system(1)|endometrium(3)|large_intestine(8)|lung(4)|skin(3) 23 CTTCCTCCAGGGTCATTTCAT 0.597 TP53 7157 broad.mit.edu 37 17 7577538 7577538 + Missense_Mutation SNP C C T rs11540652 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr17:7577538C>T uc002gim.2 - 6 937 c.743G>A c.(742-744)cGg>cAg p.R248Q TP53_uc002gig.1_Missense_Mutation_p.R248Q|TP53_uc002gih.3_Missense_Mutation_p.R248Q|TP53_uc010cne.1_5'Flank|TP53_uc010cng.1_Missense_Mutation_p.R116Q|TP53_uc010cnf.1_Missense_Mutation_p.R116Q|TP53_uc002gii.1_Missense_Mutation_p.R116Q|TP53_uc010cni.1_Missense_Mutation_p.R248Q|TP53_uc010cnh.1_Missense_Mutation_p.R248Q|TP53_uc002gij.2_Missense_Mutation_p.R248Q|TP53_uc010cnj.1_Non-coding_Transcript|TP53_uc002gin.2_Missense_Mutation_p.R155Q|TP53_uc002gio.2_Missense_Mutation_p.R116Q|DL476309_uc021tpg.1_5'Flank|DL476358_uc021tph.1_5'Flank NM_001126112 NP_001119587 P04637 P53_HUMAN Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA. 248 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain. NR -> IP (in a sporadic cancer; somatic mutation).|NR -> KW (in sporadic cancers; somatic mutation).|R -> C (in a sporadic cancer; somatic mutation).|R -> G (in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs11540652).|R -> W (in LFS; germline mutation and in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R248Q(1145)|p.R248W(513)|p.R248L(145)|p.R248P(35)|p.R155Q(18)|p.R248G(12)|p.N247N(10)|p.R248R(10)|p.0?(8)|p.N247S(7)|p.N247D(5)|p.?(5)|p.N247_R248delNR(4)|p.M246_P250delMNRRP(4)|p.N247T(4)|p.N247I(3)|p.R155L(3)|p.N247Y(3)|p.R248fs*16(3)|p.N247_P250delNRRP(2)|p.N247_R248>KW(2)|p.R155P(2)|p.R248_P250delRRP(2)|p.N247_R249delNRR(2)|p.R248C(2)|p.R248fs*97(2)|p.N247_R248>IP(2)|p.N247K(2)|p.unknown(1)|p.R248fs*>39(1)|p.N247F(1)|p.R249fs*96(1)|p.R248Y(1)|p.G245fs*14(1)|p.N247fs*98(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GATGGGCCTCCGGTTCATGCC 0.572 R248Q(BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(CA46_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(DB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(HCC1143_BREAST)|R248Q(HCC70_BREAST)|R248Q(HEC1A_ENDOMETRIUM)|R248Q(HS683_CENTRAL_NERVOUS_SYSTEM)|R248Q(HSC4_UPPER_AERODIGESTIVE_TRACT)|R248Q(KASUMI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KOPN8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KYO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KYSE150_OESOPHAGUS)|R248Q(MOLM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NAMALWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NB4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NCIH211_LUNG)|R248Q(NCIN87_STOMACH)|R248Q(NIHOVCAR3_OVARY)|R248Q(NUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(PANC0203_PANCREAS)|R248Q(PC14_LUNG)|R248Q(PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(RT112_URINARY_TRACT)|R248Q(SEM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(SF295_CENTRAL_NERVOUS_SYSTEM)|R248Q(SKUT1_SOFT_TISSUE)|R248Q(SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(SW1463_LARGE_INTESTINE)|R248Q(WSUDLCL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE) 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) NF1 4763 broad.mit.edu 37 17 29586049 29586049 + Splice_Site SNP G G A rs149784315 by1000genomes TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr17:29586049G>A uc002hgg.3 + 33 4716 c.4333_splice c.e33-1 p.I1445_splice NF1_uc002hgh.3_Splice_Site_p.I1424_splice|NF1_uc002hgi.1_Splice_Site_p.I457_splice NM_001042492 NP_001035957 P21359 NF1_HUMAN Homo sapiens neurofibromin 1 (NF1), transcript variant 1, mRNA. 1445 Ras-GAP. actin cytoskeleton organization|adrenal gland development|artery morphogenesis|camera-type eye morphogenesis|cerebral cortex development|collagen fibril organization|forebrain astrocyte development|forebrain morphogenesis|heart development|liver development|MAPKKK cascade|metanephros development|myelination in peripheral nervous system|negative regulation of cell migration|negative regulation of endothelial cell proliferation|negative regulation of MAP kinase activity|negative regulation of MAPKKK cascade|negative regulation of neuroblast proliferation|negative regulation of oligodendrocyte differentiation|negative regulation of transcription factor import into nucleus|osteoblast differentiation|phosphatidylinositol 3-kinase cascade|pigmentation|positive regulation of adenylate cyclase activity|positive regulation of neuron apoptosis|Ras protein signal transduction|regulation of blood vessel endothelial cell migration|regulation of bone resorption|response to hypoxia|smooth muscle tissue development|spinal cord development|sympathetic nervous system development|visual learning|wound healing axon|cytoplasm|dendrite|intrinsic to internal side of plasma membrane|nucleus protein binding|Ras GTPase activator activity p.0?(8)|p.?(6) NF1/ACCN1(2) autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9) 599 all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659) UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146) TTATTGTGTAGATACTTCAGA 0.303 """D, Mis, N, F, S, O""" """neurofibroma, glioma""" """neurofibroma, glioma""" Neurofibromatosis, type 1 TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088) BZRAP1 9256 broad.mit.edu 37 17 56382781 56382781 + Silent SNP C C A rs149705380 byFrequency TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr17:56382781C>A uc002ivx.4 - 28 6271 c.5400G>T c.(5398-5400)gtG>gtT p.V1800V BZRAP1_uc002ivv.3_5'Flank|BZRAP1_uc002ivw.3_Silent_p.V32V|BZRAP1_uc010dcs.3_Silent_p.V1740V|BZRAP1_uc010wnt.2_Silent_p.V1791V NM_004758 NP_004749 O95153 RIMB1_HUMAN Homo sapiens benzodiazapine receptor (peripheral) associated protein 1 (BZRAP1), transcript variant 1, mRNA. 1800 SH3 3. mitochondrion benzodiazepine receptor binding cervix(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(11)|liver(2)|lung(16)|ovary(1)|prostate(1)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1) 54 Medulloblastoma(34;0.127)|all_neural(34;0.237) TGCCCCCAAACACAGTAATGA 0.587 ITGB4 3691 broad.mit.edu 37 17 73729694 73729694 + Silent SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr17:73729694C>T uc002jpg.3 + 12 1765 c.1578C>T c.(1576-1578)taC>taT p.Y526Y ITGB4_uc002jph.3_Silent_p.Y526Y|ITGB4_uc010dgo.3_Silent_p.Y526Y|ITGB4_uc002jpi.4_Silent_p.Y526Y|ITGB4_uc010dgp.1_Silent_p.Y526Y|ITGB4_uc002jpj.3_Silent_p.Y526Y|ITGB4_uc010wsh.1_Silent_p.Y81Y NM_000213 NP_000204 P16144 ITB4_HUMAN Homo sapiens integrin, beta 4 (ITGB4), transcript variant 1, mRNA. 526 Cysteine-rich tandem repeats. cell communication|cell motility|cell-matrix adhesion|hemidesmosome assembly|integrin-mediated signaling pathway|multicellular organismal development|response to wounding cell leading edge|cell surface|hemidesmosome|integrin complex protein binding|receptor activity breast(2)|central_nervous_system(1)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(3)|liver(1)|lung(25)|skin(1)|urinary_tract(1) 43 all_cancers(13;1.5e-07) all cancers(21;8.32e-07)|Epithelial(20;1.92e-06)|BRCA - Breast invasive adenocarcinoma(9;0.00194)|Lung(188;0.132)|LUSC - Lung squamous cell carcinoma(166;0.154) GTGTGTGCTACGGCGAAGGCC 0.642 TMEM241 85019 broad.mit.edu 37 18 20889649 20889649 + Silent SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr18:20889649C>T uc002kuf.3 - 13 934 c.825G>A c.(823-825)acG>acA p.T275T TMEM241_uc010xaq.2_Non-coding_Transcript|TMEM241_uc010xar.2_Non-coding_Transcript|TMEM241_uc002kug.3_Non-coding_Transcript|TMEM241_uc002kuh.3_Non-coding_Transcript|TMEM241_uc002kue.3_Non-coding_Transcript NM_032933 NP_116322 Q24JQ0 CR045_HUMAN Homo sapiens transmembrane protein 241 (TMEM241), mRNA. 275 integral to membrane p.T275T(1) CTTACCATCCCGTGGTTGCAC 0.398 PEX11G 92960 broad.mit.edu 37 19 7542216 7542217 + Frame_Shift_Ins INS - - C TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr19:7542216_7542217insC uc002mgk.1 - 4 606_607 c.597_598insG c.(595-600)ctgcccfs p.L199fs PEX11G_uc002mgl.1_Frame_Shift_Ins_p.L129fs NM_080662 NP_542393 Q96HA9 PX11C_HUMAN Homo sapiens peroxisomal biogenesis factor 11 gamma (PEX11G), mRNA. 199 integral to membrane|peroxisomal membrane central_nervous_system(1)|cervix(1)|endometrium(1)|lung(1)|ovary(1)|prostate(1)|skin(1) 7 ACGCCCCGGGGCAGCCAGTGCA 0.713 ZNF99 7652 broad.mit.edu 37 19 22940645 22940645 + Missense_Mutation SNP A A T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr19:22940645A>T uc021urt.1 - 3 2221 c.2066T>A c.(2065-2067)tTc>tAc p.F689Y NM_001080409 NP_001073878 Homo sapiens zinc finger protein 99 (ZNF99), mRNA. p.K689E(3) NS(1)|breast(1)|central_nervous_system(3)|endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(20)|lung(55)|ovary(2)|prostate(10)|skin(5)|stomach(9)|upper_aerodigestive_tract(2)|urinary_tract(3) 124 Lung NSC(12;0.0207)|all_lung(12;0.0214)|all_epithelial(12;0.102) AAGGGCTGAGAAATGGTTAAA 0.368 KIAA0355 9710 broad.mit.edu 37 19 34819037 34819037 + Missense_Mutation SNP A A G TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr19:34819037A>G uc002nvd.4 + 5 1944 c.1085A>G c.(1084-1086)gAc>gGc p.D362G NM_014686 NP_055501 O15063 K0355_HUMAN Homo sapiens KIAA0355 (KIAA0355), mRNA. 362 breast(1)|endometrium(7)|kidney(1)|large_intestine(4)|lung(15)|ovary(2)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(3) 41 Esophageal squamous(110;0.162) TCGGCCGCCGACAATCTGAAA 0.512 DPF1 8193 broad.mit.edu 37 19 38713080 38713080 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr19:38713080G>A uc021uty.1 - 2 323 c.296C>T c.(295-297)aCg>aTg p.T99M DPF1_uc002ohm.3_Missense_Mutation_p.T99M|DPF1_uc002ohl.3_Missense_Mutation_p.T99M|DPF1_uc002ohn.3_Missense_Mutation_p.T17M|DPF1_uc010xtw.1_Missense_Mutation_p.T73M NM_001135155 NP_001128627 Q92782 DPF1_HUMAN Homo sapiens D4, zinc and double PHD fingers family 1 (DPF1), transcript variant 1, mRNA. 99 induction of apoptosis|nervous system development|regulation of transcription, DNA-dependent|transcription, DNA-dependent cytoplasm|nBAF complex zinc ion binding large_intestine(1)|lung(4)|ovary(1)|skin(1) 7 all_cancers(60;1.24e-06) Lung(45;0.000246)|LUSC - Lung squamous cell carcinoma(53;0.000292) GGCGGGGTACGTGTAAATCTG 0.697 FAM126B 285172 broad.mit.edu 37 2 201857004 201857004 + Silent SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr2:201857004C>T uc002uws.4 - 10 1019 c.831_splice c.e10+1 p.L277_splice FAM126B_uc002uwu.3_Splice_Site_p.L195_splice|FAM126B_uc002uwv.3_Splice_Site_p.L277_splice NM_173822 NP_776183 Q8IXS8 F126B_HUMAN Homo sapiens family with sequence similarity 126, member B (FAM126B), mRNA. 277 intracellular endometrium(2)|kidney(1)|large_intestine(3)|lung(5)|ovary(2)|prostate(2)|upper_aerodigestive_tract(1) 16 AATAACTTACCAATAGTGGTT 0.333 IRS1 3667 broad.mit.edu 37 2 227662172 227662172 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr2:227662172G>A uc021vxn.1 - 0 1283 c.1283C>T c.(1282-1284)tCg>tTg p.S428L IRS1_uc002voh.4_Missense_Mutation_p.S428L NM_005544 NP_005535 P35568 IRS1_HUMAN Homo sapiens insulin receptor substrate 1 (IRS1), mRNA. 428 Ser-rich. fibroblast growth factor receptor signaling pathway|glucose homeostasis|insulin receptor signaling pathway|negative regulation of insulin receptor signaling pathway|negative regulation of insulin secretion|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol-mediated signaling|positive regulation of fatty acid beta-oxidation|positive regulation of glucose import|positive regulation of glycogen biosynthetic process|positive regulation of insulin receptor signaling pathway|positive regulation of phosphatidylinositol 3-kinase activity caveola|cytosol|insulin receptor complex|microsome|nucleus insulin receptor binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase binding|protein kinase C binding|SH2 domain binding|transmembrane receptor protein tyrosine kinase adaptor activity p.S428L(2) autonomic_ganglia(1)|breast(2)|central_nervous_system(4)|endometrium(5)|kidney(4)|large_intestine(10)|lung(33)|ovary(6)|pancreas(1)|prostate(1)|urinary_tract(2) 69 Renal(207;0.023)|all_lung(227;0.0994)|all_hematologic(139;0.118)|Esophageal squamous(248;0.23) Epithelial(121;3.03e-11)|all cancers(144;2.42e-08)|Lung(261;0.00712)|LUSC - Lung squamous cell carcinoma(224;0.0137) ATACTCATCCGAGGAGATGAA 0.617 OREG0015248 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) TAF4 6874 broad.mit.edu 37 20 60581775 60581775 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr20:60581775C>T uc002ybs.3 - 6 2014 c.2014G>A c.(2014-2016)Gcg>Acg p.A672T NM_003185 NP_003176 O00268 TAF4_HUMAN Homo sapiens TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa (TAF4), mRNA. 672 TAFH. interspecies interaction between organisms|positive regulation of transcription, DNA-dependent|transcription elongation from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|viral reproduction cytoplasm|MLL1 complex|transcription factor TFIID complex|transcription factor TFTC complex DNA binding|protein binding|sequence-specific DNA binding transcription factor activity|transcription coactivator activity central_nervous_system(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(5)|lung(15)|ovary(2)|pancreas(1)|prostate(2)|skin(4)|upper_aerodigestive_tract(1) 37 Breast(26;1e-08) BRCA - Breast invasive adenocarcinoma(19;3.1e-07) ATGAAGGCCGCGGAGTCGGGG 0.662 KRTAP6-3 337968 broad.mit.edu 37 21 31964779 31964779 + Silent SNP C C A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr21:31964779C>A uc002yom.3 + 0 21 c.15C>A c.(13-15)acC>acA p.T5T KRTAP22-2_uc021wih.1_5'Flank NM_181605 NP_853636 Homo sapiens keratin associated protein 6-3 (KRTAP6-3), mRNA. endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|lung(7) 10 CCTCAACAACCAACACCATGT 0.522 FLNB 2317 broad.mit.edu 37 3 58140654 58140654 + Silent SNP T T C TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr3:58140654T>C uc003djj.2 + 40 6937 c.6772_splice c.e40+1 p.G2258_splice FLNB_uc010hne.2_Splice_Site_p.G2289_splice|FLNB_uc003djk.2_Splice_Site_p.G2247_splice|FLNB_uc010hnf.2_Splice_Site_p.G2234_splice|FLNB_uc003djl.2_Splice_Site_p.G2078_splice|FLNB_uc003djm.2_Splice_Site_p.G2065_splice NM_001457 NP_001448 O75369 FLNB_HUMAN Homo sapiens filamin B, beta (FLNB), transcript variant 2, mRNA. 2258 Interaction with INPPL1. actin cytoskeleton organization|cell differentiation|cytoskeletal anchoring at plasma membrane|signal transduction cell cortex|integral to membrane|nucleus|sarcomere actin binding p.G2258fs*36(1) NS(1)|breast(13)|central_nervous_system(2)|endometrium(10)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(23)|liver(2)|lung(38)|ovary(6)|prostate(3)|skin(8)|upper_aerodigestive_tract(3)|urinary_tract(5) 120 BRCA - Breast invasive adenocarcinoma(55;0.000335)|KIRC - Kidney renal clear cell carcinoma(284;0.0726)|Kidney(284;0.0898) CCCAAGAGCCTGGTATGTATT 0.453 SLC9C1 285335 broad.mit.edu 37 3 111887770 111887770 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr3:111887770C>T uc003dyu.3 - 24 3413 c.3191G>A c.(3190-3192)cGa>cAa p.R1064Q SLC9C1_uc011bhu.2_Missense_Mutation_p.R327Q|SLC9C1_uc010hqc.3_Missense_Mutation_p.R1016Q NM_183061 NP_898884 Q4G0N8 S9A10_HUMAN Homo sapiens solute carrier family 9, member 10 (SLC9A10), mRNA. 1064 cell differentiation|multicellular organismal development|sodium ion transport|spermatogenesis cilium|flagellar membrane|integral to membrane solute:hydrogen antiporter activity p.R1064Q(1) ATAAGTTTTTCGTAACAGACA 0.323 HLTF 6596 broad.mit.edu 37 3 148804115 148804115 + Nonsense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr3:148804115C>T uc003ewq.1 - 0 227 c.9G>A c.(7-9)tgG>tgA p.W3* HLTF_uc003ewr.1_Nonsense_Mutation_p.W3*|HLTF_uc003ews.1_Nonsense_Mutation_p.W3*|HLTF_uc010hve.1_Nonsense_Mutation_p.W3* NM_139048 NP_620636 Q14527 HLTF_HUMAN Homo sapiens helicase-like transcription factor (HLTF), transcript variant 2, mRNA. 3 chromatin modification|transcription, DNA-dependent nucleus ATP binding|DNA binding|helicase activity|ligase activity|zinc ion binding breast(2)|cervix(1)|endometrium(5)|kidney(3)|large_intestine(9)|lung(18)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2) 47 LUSC - Lung squamous cell carcinoma(72;0.0473)|Lung(72;0.0607) TCTTGAACATCCAGGACATGG 0.652 PIK3CA 5290 broad.mit.edu 37 3 178936082 178936082 + Missense_Mutation SNP G G A rs121913273 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr3:178936082G>A uc003fjk.3 + 9 1781 c.1624G>A c.(1624-1626)Gaa>Aaa p.E542K NM_006218 NP_006209 P42336 PK3CA_HUMAN Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA), mRNA. 542 PI3K helical. E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation).|E -> Q (in cancer).|E -> V (in cancer). epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway 1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity p.E542K(1231)|p.E542Q(18)|p.E542V(8)|p.(542_545)E>K(4)|p.E542G(2)|p.E542A(2)|p.S541T(1) NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208) 5269 all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155) OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282) TCCTCTCTCTGAAATCACTGA 0.333 E542K(BT483_BREAST)|E542K(CAL51_BREAST)|E542K(HGC27_STOMACH)|E542K(IM95_STOMACH)|E542K(JHUEM1_ENDOMETRIUM)|E542K(NCIH1341_LUNG)|E542K(SW948_LARGE_INTESTINE)|E542K(T84_LARGE_INTESTINE)|E542K(VMCUB1_URINARY_TRACT) 57 Mis """colorectal, gastric, gliobastoma, breast""" HNSCC(19;0.045)|TSP Lung(28;0.18) LARP1B 55132 broad.mit.edu 37 4 129003366 129003366 + Silent SNP A A G TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr4:129003366A>G uc003iga.3 + 4 395 c.264A>G c.(262-264)tcA>tcG p.S88S LARP1B_uc003ifw.1_Intron|LARP1B_uc003ifx.3_Silent_p.S88S|LARP1B_uc003ify.3_Silent_p.S88S|LARP1B_uc003ifz.1_Silent_p.S88S NM_018078 NP_060548 Q659C4 LAR1B_HUMAN Homo sapiens La ribonucleoprotein domain family, member 1B (LARP1B), transcript variant 1, mRNA. 88 RNA binding endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(7)|lung(11)|ovary(1)|prostate(3) 34 TTGTAAGATCAGAGAGTCAAG 0.373 PCDHAC2 56147 broad.mit.edu 37 5 140167909 140167909 + Silent SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr5:140167909G>A uc003lhb.2 + 0 2034 c.2034G>A c.(2032-2034)gcG>gcA p.A678A PCDHAC2_uc003lha.2_Intron|PCDHAC2_uc003lgz.3_Silent_p.A678A NM_018900 NP_061723 Q9Y5I4 PCDC2_HUMAN Homo sapiens protocadherin alpha 1 (PCDHA1), transcript variant 1, mRNA. 687 Cadherin 6. homophilic cell adhesion|nervous system development integral to plasma membrane calcium ion binding p.A678A(2) NS(1)|breast(1)|endometrium(4)|kidney(4)|large_intestine(10)|liver(2)|lung(9)|ovary(2)|prostate(1)|skin(7)|upper_aerodigestive_tract(3)|urinary_tract(1) 45 KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191) CGCCAAAGGCGTCTTCGCGGG 0.662 HRH2 3274 broad.mit.edu 37 5 175110363 175110363 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr5:175110363G>A uc003mdc.4 + 1 771 c.127G>A c.(127-129)Gtg>Atg p.V43M HRH2_uc003mdd.2_Missense_Mutation_p.V43M NM_001131055 NP_001124527 P25021 HRH2_HUMAN Homo sapiens histamine receptor H2 (HRH2), transcript variant 1, mRNA. 43 G-protein signaling, coupled to cyclic nucleotide second messenger|immune response integral to plasma membrane histamine receptor activity breast(1)|cervix(1)|endometrium(3)|large_intestine(6)|lung(10)|ovary(1) 22 all_cancers(89;0.00805)|Renal(175;0.000269)|Lung NSC(126;0.00419)|all_lung(126;0.00711) Medulloblastoma(196;0.0208)|all_neural(177;0.0277)|all_hematologic(541;0.214) Kidney(164;3.85e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000183) Colorectal(1;0.0154)|COAD - Colon adenocarcinoma(1;0.149) Betazole(DB00272)|Cimetidine(DB00501)|Doxepin(DB01142)|Epinastine(DB00751)|Famotidine(DB00927)|Histamine Phosphate(DB00667)|Nizatidine(DB00585)|Ranitidine(DB00863) CTGTCTGGCCGTGGGCTTGAA 0.587 SEMA3C 10512 broad.mit.edu 37 7 80546078 80546078 + Missense_Mutation SNP C C A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr7:80546078C>A uc011kgw.2 - 1 153 c.74G>T c.(73-75)tGc>tTc p.C25F SEMA3C_uc003uhj.3_Missense_Mutation_p.C7F|SEMA3C_uc011kgx.1_5'UTR NM_006379 NP_006370 Q99985 SEM3C_HUMAN Homo sapiens sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C (SEMA3C), mRNA. 7 immune response|response to drug membrane receptor activity p.P25H(1) NS(2)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(17)|ovary(1)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(1) 34 AACCAACACGCAAATTGTCCG 0.353 PDIA4 9601 broad.mit.edu 37 7 148703125 148703125 + Silent SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr7:148703125G>A uc003wff.2 - 7 1434 c.1152C>T c.(1150-1152)gcC>gcT p.A384A NM_004911 NP_004902 P13667 PDIA4_HUMAN Homo sapiens protein disulfide isomerase family A, member 4 (PDIA4), mRNA. 384 cell redox homeostasis|glycerol ether metabolic process|protein secretion endoplasmic reticulum lumen|melanosome electron carrier activity|protein binding|protein disulfide isomerase activity|protein disulfide oxidoreductase activity large_intestine(6)|lung(15)|ovary(2)|prostate(1) 24 Melanoma(164;0.15) OV - Ovarian serous cystadenocarcinoma(82;0.00385) AGTCCTTGATGGCCGAGTCCT 0.592 OREG0018420 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) ZDHHC2 51201 broad.mit.edu 37 8 17072848 17072848 + Silent SNP A A G TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr8:17072848A>G uc003wxe.3 + 10 1450 c.1053A>G c.(1051-1053)aaA>aaG p.K351K NM_016353 NP_057437 Q9UIJ5 ZDHC2_HUMAN Homo sapiens zinc finger, DHHC-type containing 2 (ZDHHC2), mRNA. 351 integral to membrane acyltransferase activity|zinc ion binding endometrium(1)|kidney(1)|large_intestine(3)|lung(1)|pancreas(1)|stomach(1) 8 Colorectal(111;0.0697)|COAD - Colon adenocarcinoma(73;0.244) ACCCAGGAAAATGCAAAGCTG 0.403 FBXO16 157574 broad.mit.edu 37 8 28321322 28321322 + Missense_Mutation SNP G G T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr8:28321322G>T uc003xgu.3 - 3 247 c.149C>A c.(148-150)aCa>aAa p.T50K ZNF395_uc003xgt.3_5'UTR|FBXO16_uc003xgv.3_Missense_Mutation_p.T37K NM_172366 NP_758954 Q8IX29 FBX16_HUMAN Homo sapiens F-box protein 16 (FBXO16), mRNA. 50 large_intestine(2)|ovary(1) 3 Ovarian(32;2.06e-05) KIRC - Kidney renal clear cell carcinoma(542;0.121)|Kidney(114;0.144)|Colorectal(74;0.249) TTGAGAGTCTGTCCATTTGTC 0.428 KIAA0020 9933 broad.mit.edu 37 9 2829854 2829854 + Missense_Mutation SNP C C T rs62534389 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr9:2829854C>T uc003zhp.1 - 7 868 c.772G>A c.(772-774)Gca>Aca p.A258T KIAA0020_uc003zhq.1_Missense_Mutation_p.A257T NM_014878 NP_055693 Q15397 K0020_HUMAN Homo sapiens KIAA0020 (KIAA0020), mRNA. 258 PUM-HD. endoplasmic reticulum|nucleolus RNA binding NS(1)|breast(2)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(7)|lung(4)|ovary(1) 21 GBM - Glioblastoma multiforme(50;0.0319) TCATTGTATGCGTACTCCACG 0.458 FAM219A 203259 broad.mit.edu 37 9 34401054 34401054 + Missense_Mutation SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr9:34401054C>T uc011lok.2 - 5 773 c.466G>A c.(466-468)Gac>Aac p.D156N FAM219A_uc003zuj.3_Missense_Mutation_p.D139N|FAM219A_uc011lol.2_Missense_Mutation_p.D144N|FAM219A_uc003zul.3_Missense_Mutation_p.D127N|FAM219A_uc022bgc.1_Missense_Mutation_p.D155N|FAM219A_uc022bgd.1_Missense_Mutation_p.D138N|FAM219A_uc003zuk.3_Missense_Mutation_p.D128N NM_001184940 NP_001171869 Q8IW50 CI025_HUMAN Homo sapiens chromosome 9 open reading frame 25 (C9orf25), transcript variant 1, mRNA. 156 AGGTCCTCGTCGTCGGGGATC 0.617 FAM75C1 441452 broad.mit.edu 37 9 90537820 90537820 + Missense_Mutation SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr9:90537820G>A uc010mqi.3 + 3 3027 c.2998G>A c.(2998-3000)Gtc>Atc p.V1000I FAM75C1_uc004apq.4_Missense_Mutation_p.V983I|DQ578031_uc022bjg.1_5'Flank NM_001145124 NP_001138596 Homo sapiens family with sequence similarity 75, member C1 (FAM75C1), mRNA. GAATGAAGGCGTCCAGCTACT 0.408 EGFL7 51162 broad.mit.edu 37 9 139564727 139564727 + Silent SNP C C T TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chr9:139564727C>T uc004cid.3 + 6 1427 c.516C>T c.(514-516)gaC>gaT p.D172D EGFL7_uc010nbp.3_Silent_p.D172D|EGFL7_uc004cie.3_Silent_p.D172D|EGFL7_uc004cif.3_Silent_p.D172D|EGFL7_uc004cih.3_Silent_p.D172D|MIR126_uc022bps.1_5'Flank NM_201446 NP_958854 Q9UHF1 EGFL7_HUMAN Homo sapiens EGF-like-domain, multiple 7 (EGFL7), transcript variant 2, mRNA. 172 EGF-like 2; calcium-binding (Potential). angiogenesis|vasculogenesis calcium ion binding kidney(2)|ovary(1)|prostate(2)|urinary_tract(1) 6 all_cancers(76;0.109) Myeloproliferative disorder(178;0.0511) OV - Ovarian serous cystadenocarcinoma(145;9.87e-06)|Epithelial(140;0.000123) TGTCTGCAGACGGTACACTCT 0.677 ZNF280C 55609 broad.mit.edu 37 X 129370452 129370452 + Silent SNP G G A TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-10A-01D-1490-08 Untested Somatic Phase_I WXS none Illumina GAIIx 39d1f122-31d0-4e1c-95a7-0e65e75b1457 d456abad-4114-4c44-9d80-fe569abe7cda g.chrX:129370452G>A uc004evm.3 - 6 858 c.655C>T c.(655-657)Ctg>Ttg p.L219L ZNF280C_uc010nrf.2_Silent_p.L219L NM_017666 NP_060136 Q8ND82 Z280C_HUMAN Homo sapiens zinc finger protein 280C (ZNF280C), mRNA. 219 Ser-rich. regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding endometrium(3)|kidney(4)|large_intestine(9)|lung(6)|ovary(1)|skin(2)|upper_aerodigestive_tract(1) 26 CCTTTTGACAGCATAACTTGG 0.328